According to SPER Market Research, the Global Next-generation Sequencing (NGS) Market primary drivers of the market expansion are the rising incidence of cancer, improvements in regulatory and reimbursement frameworks for NGS-based diagnostic tests, declining costs of genome sequencing, growing applications of next-generation sequencing in cancer research, and advancements in NGS platforms.
Research and development in developing nations primarily depends on outside funding due to ethical concerns, the interpretation of complex data from NGS platforms, the introduction of alternative technologies, and other factors. The biggest barrier preventing market expansion in emerging nations is tight budgets.
Global Next-generation Sequencing (NGS) Market Overview (2022-2030)
Forecast CAGR (2022-2030): 17.5%.
Forecast Market Size (2030): 43.97 billion.
The use of molecular diagnostics, NGS in personalized medicine, and government support for high-throughput sequencing open up a wide range of opportunities for market participants.
From the Product & Service, Technology, Application, and End-User categories, respectively, the sequencing by synthesis section, NGS consumables segment, diagnostics segment, and academic institutes & research centers segment command the largest proportion of the market.
Impact of COVID-19 on the Next-generation Sequencing (NGS) Market Industry
Research on vaccinations, test kits, and treatments has been supported by pharmaceutical and biopharmaceutical firms as well as start-ups in the NGS industry. the extensive research and development carried out by businesses to create new pharmaceuticals to treat infections. The Next-generation Sequencing (NGS) Market benefits from COVID-19.
Request For Free sample report @ https://www.sperresearch.com/report-store/Next-generation-Sequencing.aspx?sample=1
Global Next-generation Sequencing (NGS) Market Key Segments Covered:
The SPER Market Research report seeks to give market dynamics, demand, and supply forecasts for the years up to 2030. This report contains statistics on product type segment growth estimates and forecasts.
By Product:
- NGS Consumables.
- Sequencing Services.
- Other Sequencing Services.
By Technology:
- Sequencing by Synthesis.
- Single-Molecule Real-Time Sequencing.
- Nanopore Sequencing.
- And Other Technologies are examples of sequencing techniques.
By Application:
- Drug Discovery.
- Agricultural & Animal Research.
- and Other Applications.
- Diagnostics.
By End User:
- Hospitals & clinics.
- Pharmaceutical & biotechnology firms.
- Academic research institutions, and other end users.
By Region:
- North America
- Europe
- Asia-Pacific
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies for this market. It traces the market's historic and forecast market growth by geography.
Next-generation Sequencing (NGS) Market Key Players:
The global Next-generation Sequencing (NGS) Market study provides market data by the competitive landscape, revenue analysis, market segments, and detailed analysis of key market players such as; Molecular Biology Resources, Novo gene Co., Ltd., Nugen Technologies, Oxford Nanopore Technologies, Promega, Psoralen, Pacific Biosciences, PerkinElmer, QIAGEN, Randox, Roche, Takara Bio, Thermon Fisher, Zimo Research Corporation, 10x Genomics, Agilent Technologies, Beckman Coulter, BGI Group, Dickinson and Company, Eurofins, F. Hoffmann-La Roche AG, GENEWIZ.
For More Information, refer to below link: -
Next-generation Sequencing (NGS) Market Size
Related Reports:
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
SPER Market Research
Anthony tone Business Consultant – U.S.A.
+1-347-460-2899
New York, NY 13 May 2021: The global next generation sequencing market expected to reach US$ 25.85 billion by 2028 according to a new study by Polaris Market Research.
The report “Next Generation Sequencing (NGS) Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious Diseases, Agricultural & Animal Research); By Technology; By Product; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Market players are focusing on developing automated sequencers equipped with high speed and accuracy.
This has also enabled increased adoption in emerging nations.
In terms of application, the market is segmented into drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-sample Segment HighlightsInfectious diseases segment is estimated to hold a major share in the global next generation sequencing market, owing to increasing usage of NGS in infectious diseases.
Next Generation Sequencing Market Research Report: By Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome Sequencing), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), Application (Oncology, Clinical Investigation, Reproductive Health, Human Leukocyte Antigen Typing or Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, Consumer Genomics), End User (Hospitals & Clinics, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Global Forecast till 2025Global Next Generation Sequencing Market Share is expected to exhibit significant growth over the forecast period.
The NGS Market Growth is projected to register a CAGR of 18.05% over the forecast period to reach USD 20,347.45 Million by 2025.There are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease etc.
To discover viable treatment to these diseases, researchers are looking to discern how genes work.
Next generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to field of genomics.
The NGS technologies are implemented for several applications, including whole genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level.
The successful application of next-generation sequencing can lead to predicting of genes, protein coding regions, and pathways.Illumina, Helicos Biosciences, Thermo Fisher Scientific, Roche, Pacific Bioscience, ABI Life Technologies, and Oxford Nanopore are some of the companies that are implementing different NGS technologies which in turn will augment global next generation sequencing market which is estimated to reach a massive market valuation by 2023.Next Generation Sequencing Market Competitive Landscape:Some of the key players in the global next-generation sequencing market Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., BGI, PerkinElmer, Agilent Technologies, QIAGEN N. V., Macrogen Inc., Oxford Nanopore Technologies, Ltd., and Eurofins Scientific.
The global Next Generation Sequencing Market report offers a comprehensive assessment of the market for the forecast years.
The report contains several segments and an analysis of the market trends and growth factors that are playing a vital role in the market.
This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2030.The leading companies in Global Next Generation Sequencing Market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile, and STD Reimbursement Scenario Analysis, and Top Study Testing Technologies products and services.The key market players for the global Next Generation Sequencing Market are listed below:Agilent Technologies, IncBGI Group F. Hoffmann-La Roche AG Illumina IncPrecigen Inc., (Intrexon Bioinformatics Germany GmbH)Pacific Biosciences of California, IncPerkinElmer, Inc.PierianDx Inc.Qiagen N.V.Thermo Fisher Scientific Inc.(A PDF | Sample Of The Report Is Available Immediately Upon Request) @ https://www.alliedmarketresearch.com/request-sample/2048 The Global Next Generation Sequencing Market Report is equipped with market data from 2021 to 2030.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.Covid-19 Scenario:1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.Detailed COVID-19 Impact Analysis on Market: https://www.alliedmarketresearch.com/request-for-customization/2048?reqfor=covid Why Purchase this Report?A robust research methodology has been followed to collect data for the report.
Data, thus collected passes through multiple quality checks to ensure the best quality is served.The report gives a holistic view of the competitive scenario of the Next Generation Sequencing Market.The latest product launches along with technological changes and development are covered in the report.The data analysis in the report helps in understanding the anticipated Next Generation Sequencing Market dynamics from 2021 to 2030.Decision Databases has a vast repository of data, therefore, we can accommodate customized requirements also.The graphs, tables and pie charts, and info-graphics covered in the report will help in a better understanding of the report.The market drivers, restraints, upcoming opportunities, and anticipated restraints cited in the report will assist in making an informed decision.Interested in Procuring this Report?
